Silent symptoms that precede Parkinson's disease and the importance of early diagnosis
Medical experts have confirmed that Parkinson's disease, also known as paralysis agitans, results from a deficiency of dopamine in the brain and an accumulation of the protein alpha-synuclein. They noted that there are silent, non-motor symptoms that may precede tremors and stiffness by many years. This came during their remarks on World Parkinson's Day, where they explained that early diagnosis opens the door to advanced treatment options, including implanted devices and deep brain stimulation. They emphasized the importance of psychological and social support to avoid stigma and help patients adapt to physical and functional changes.
Historical roots: The discovery and development of Parkinson's disease
The first medical description of this neurological disorder is attributed to the English physician James Parkinson in 1817, who named it “shaking palsy.” Since then, medical research has witnessed tremendous progress in understanding brain mechanisms and how dopamine deficiency affects motor and non-motor functions. Historically, the disease was thought to be limited to the elderly, but recent studies have demonstrated its potential to appear at younger ages, prompting the global medical community to intensify efforts to develop more accurate and effective diagnostic and treatment methods to reduce the progression of symptoms.
The health and social impact of the disease's spread regionally and internationally
This disease has a significant impact both locally and internationally, being the second most common neurodegenerative disease in the world after Alzheimer's. With increasing life expectancy globally, the World Health Organization anticipates a substantial rise in the number of people affected, posing a significant challenge to healthcare systems. Locally and regionally, strengthening medical infrastructure and providing specialized rehabilitation centers is crucial, along with launching awareness campaigns to reduce the social stigma associated with the disease. This will contribute to the effective integration of patients into their communities and alleviate the economic and psychological burden on families.
An integrated approach to managing motor and non-motor symptoms
Dr. Abdullah Saeed Al-Amri, a consultant neurologist specializing in genetic diseases and movement disorders and brain stimulation at King Fahd University Hospital in Al-Khobar, explained that this chronic neurodegenerative disorder primarily affects movement. The most prominent motor symptoms include tremors in the extremities, slowness of movement, muscle rigidity, and balance problems. Conversely, non-motor symptoms that may precede the disease by years include loss of smell, sleep disturbances, depression, and anxiety. He emphasized that early diagnosis allows for the initiation of both pharmacological and non-pharmacological treatment, such as implanted devices in the digestive system or the base of the brain, which slows the decline in functional status. He also stressed the role of physical therapy and rehabilitation in improving balance and flexibility.
Neuroplasticity and the importance of early intervention
For her part, Dr. Zakia Mohammed Ismail Yasawi, Assistant Professor and Consultant Neurologist at Imam Abdulrahman bin Faisal University, confirmed that the disease is characterized by the loss of dopamine-producing nerve cells. She explained that non-motor symptoms, such as impaired sense of smell and REM sleep disturbances, represent the "prodromal phase" of the disease. She revealed that early and continuous intervention, including dopaminergic therapies and regular exercise programs, contributes to enhancing neuroplasticity and reducing the risk of falls. She emphasized the importance of placing the patient at the center of the treatment decision to preserve their dignity and independence.
Community awareness and sustained productivity
In a related context, Professor Fawaz Al-Mutairi, President of the Saudi Society for Neurosurgery, explained that early diagnosis allows for timely treatment, thus preserving the patient's quality of life for a longer period. He pointed out that family and community play a pivotal role through psychological support and creating a safe and stimulating environment. He concluded with a reassuring message that the illness is not the end; with adherence to the treatment plan, the patient can live a stable and productive life.
Modern treatments and brain stimulation techniques
Dr. Aisha Al-Bakr, a consultant neurologist and stroke specialist, confirmed that the disease often begins with a slight tremor or changes in gait and handwriting. She explained that symptoms worsen during the first five years, making early medical consultation crucial. She noted the availability of modern treatments such as deep brain stimulation for select cases, in addition to promising research advancements in cell transplantation. She emphasized that living with the disease is highly possible with awareness, treatment, and ongoing family support.
